Showing 601-610 of 2293 results for "".
Novel Treatments for Alzheimer Disease Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/novel-treatments-for-alzheimer-disease-disorders/31801/A selection of drugs currently in clinical trials organized by Common Alzheimer Disease Research Ontology focused on mechanisms of action.An Overview of Neurologic Complications of HIV and Opportunistic Infections
https://practicalneurology.com/diseases-diagnoses/imaging-testing/an-overview-of-neurologic-complications-of-hiv-and-opportunistic-infections/32154/Despite advances in treatment, neurologic complications remain prevalent in people with HIV infection.Unraveling the Impact of Environmental Factors on Sleep Quality and Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/unraveling-the-impact-of-environmental-factors-on-sleep-quality-and-parkinson-disease/32197/A review of the effects of various environmental factors—extreme temperatures, air and noise pollution, chemical exposures, and heavy metals—on both sleep and Parkinson disease.Patient-Reported Outcome Measures in Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/patient-reported-outcome-measures-in-neuromuscular-disorders/35531/Information gleaned from patient-reported outcome measures provides valuable insights into the effects of neuromuscular disorders on function and quality of life.- Practical Neurology Nominated as Finalist for 2 Eddie & Ozzie Awardshttps://practicalneurology.com/news/practical-neurology-nominated-as-finalist-for-2-eddie-ozzie-awards/2470285/Practical Neurology has been named a finalist for 2 categories in the 2023 Folio: Eddie & Ozzie Awards, a prestigious recognition program organized by Folio, a magazine industry–focused publication. Eddies are awarded on the basis of editorial excellence in publication
- Study Assesses the Quality of Life and Unmet Needs of Geriatric and Advanced MS Patientshttps://practicalneurology.com/news/study-assesses-the-quality-of-life-and-unmet-needs-of-geriatric-and-advanced-ms-patients/2470195/A study performed by members of the Medical College of Wisconsin analyzed quality of life (QOL) and rates of depression of patients with advanced multiple sclerosis (A-MS) and geriatric MS (G-MS) compared with younger patie
- “Giants of MS” Award Presented to 7 MS Leaders at 2024 CMSC Annual Meetinghttps://practicalneurology.com/news/giants-of-ms-award-presented-to-7-ms-leaders-at-2024-cmsc-annual-meeting/2470488/Several leaders in different areas of multiple sclerosis (MS) research received the “Giants of MS” award for their contributions and achievements. One recipient was selected for each of the 7 award categories, including: Advanced Care Provider, Mental Health, Neurology, Nursing, Pharm
- Relapse Patterns in MS Patients During Pregnancy and Postpartumhttps://practicalneurology.com/news/relapse-patterns-in-ms-patients-during-pregnancy-and-postpartum/2470132/A retrospective, observational study of relapse patterns in women with MS who took disease-modifying therapies (DMT) either before o
- Comorbidities Linked with Increased Disease Activity in Individuals with MShttps://practicalneurology.com/news/comorbidities-linked-with-increased-disease-activity-in-individuals-with-ms/2470579/Study results presented at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) demonstrated that higher comorbidity burden is associated with increased disease activity in people with multiple sclerosis (MS). This study emphasizes the importance
- Novel Proteomics Study Shows New Evidence of Association between NfL and MS Progression along with 11 CSF Proteins Associated with Long-Term MS Disabilityhttps://practicalneurology.com/news/novel-proteomics-study-shows-new-evidence-of-association-between-nfl-and-ms-progression-along-with-11-csf-proteins-associated-with-long-term-ms-disability/2470334/Analysis from a proteomics study published in Nature Communications revealed that neurofilament light chain (NfL) was the most powerful predictor of multiple sclerosis (MS) activity and a combination of 11 cerebrospinal fluid (CSF) proteins was useful in predicting long-term MS disabilit